"By the beginning of summer next year, the vaccine will be ready for entry into civil circulation on the Belarusian territory and at export markets. The total output volume will be about 10 million doses per year. Four million doses will be for the domestic market, with plans to put the rest of manufactured volume for the export," the state media Belarus Segodnya quotes Golovchenko as saying.
The Belarusian Sputnik V manufacturing plant will be the only of its kind in the Commonwealth of Independent States (CIS), considering the level of vaccine manufacturing equipment and technologies, according to Golovchenko.
Russia Coronavirus Vaccination
© Sputnik / Vitaliy Belousov
The minister also said that the manufacturing equipment installation was being completed and that almost all of it had already arrived.
The minister said the vaccine`s first validation series would be put into storage, testing its stability, and that the registration procedure would follow after.
Sputnik V is the world's first vaccine against COVID-19. It has shown 91.6 percent efficacy and has been approved for use in 71 countries, representing a total population of four billion people, or 50 percent of the world's populace